MSP008-22
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MSP008-22, covering 2026-02-03 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours [Phase 1]